During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office" #1 collaborator was "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are "Venous Thromboembolism" (3 trials), "Cardiovascular Disease" (1 trials), "Embolism" (1 trials), "Hypertension" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.

Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Semuloparin sodium" (3 trials), "5-Fluorouracil" (2 trials), "Enoxaparin sodium" (2 trials), "Placebo" (2 trials) and "Avidin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanofi-Aventis Administrative Office" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Sanofi-Aventis Administrative Office, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".